Patent Assignment
Reel/Frame 061314/0459
Amended and Restated Intellectual Property Security Agreement
Recorded: 2022-08-25
Pages: 47
Assignor
MELINTA THERAPEUTICS, LLC
Executed: 2022-08-23
Assignee
SILICON VALLEY BANK
3003 TASMAN DRIVE, HF 150, SANTA CLARA, CALIFORNIA, 95054
Covered Properties
(20)
Use of Oritavancin for Prevention and Treatment of Anthrax
Method of Inhibiting Clostridium Difficile by Administration of Oritavancin
Methods of Treating Bacterial Infections Using Oritavancin
Methods of Inhibiting and Treating Biofilms Using Glycopeptide Antibiotics
Methods of Treatment Using Single Doses of Oritavancin
Glycopeptide and Lipoglycopeptide Antibiotics with Improved Solubility
Disk Diffusion Assay for Oritavancin
Ribosome Structure and Protein Synthesis Inhibitors
Method of Inhibiting Clostridium Difficile by Administration of Oritavancin
Method of Inhibiting Clostridium Difficile by Administration of Oritavancin
Crystalline Forms of D-Glucitol, 1-Deoxy-1-(Methylamino)-, 1-(6-Amino-3,5-Difluoropyridine-2-Yl)-8-Chloro-6-Fluoro-1,4-Dihydro-7-(3-Hydroxyazetidin-1-Yl)-4-Oxo-3-Quinolinecarboxylate
Application:
14/773,655 →
Publication:
US 2016/0046603
High Purity Oritavancin and Method of Producing Same
Methods for Treating Bacterial Infections Using Oritavancin and Polymyxins
High Purity Oritavancin and Method of Producing Same
Methods for Treating Infections
Application:
15/696,603 →
Publication:
US 2017/0368055
Tetracycline Compositions
High Purity Oritavancin and Method of Producing Same
Synthesis of Boronate Ester Derivatives and Uses Thereof
Antimicrobial Compositions with Effervescent Agents
Application:
16/774,709 →
Publication:
US 2020/0237744
Methods of Treating Bacterial Infections with Minocycline
Application:
17/052,141 →
Publication:
US 2021/0052608
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 22, 2012
From: BELLEY, ADAM
To: THE MEDICINES COMPANY
Reel/Frame 028828/0227 →
Nunc Pro Tunc Assignment
Nov 26, 2012
From: RAFAI FAR, ADEL; NEESHAM-GRENON, EVE; MOECK, GREGORY; BELLEY, ADAM
To: TARGANTA THERAPEUTICS CORP.
Reel/Frame 029346/0321 →
Assignment of Assignor's Interest
Jul 31, 2013
From: TARGANTA THERAPEUTICS CORP.
To: THE MEDICINES COMPANY
Reel/Frame 030916/0580 →
Change of Name
Oct 17, 2013
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031432/0123 →
Assignment of Assignor's Interest
Oct 17, 2013
From: TARGANTA THERAPEUTICS CORP.
To: THE MEDICINES COMPANY
Reel/Frame 031428/0744 →
Assignment of Assignor's Interest
Dec 13, 2013
From: SUTCLIFFE, JOYCE A; OYELERE, ADEGBOYEGA K; IPPOLITO, JOSEPH A
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 031780/0329 →
Assignment of Assignor's Interest
Dec 13, 2013
From: STEITZ, THOMAS A; MOORE, PETER B
To: YALE UNIVERSITY
Reel/Frame 031780/0339 →
Assignment of Assignor's Interest
Jan 8, 2016
From: HANSELMANN, ROGER; REEVE, MAXWELL M.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 037437/0849 →
Assignment of Assignor's Interest
Feb 6, 2017
From: CHEMBURKAR, SANJAY R.; KNABLE, CARL M.; PETZEL, JAMES; PRUYNE, JULIE J.
To: ABBVIE INC.
Reel/Frame 041183/0774 →
Assignment of Assignor's Interest
Feb 7, 2017
From: RAFAI FAR, ADEL; KRISHNA, GOPAL; DING, MIN
To: THE MEDICINES COMPANY
Reel/Frame 041192/0811 →
Assignment of Assignor's Interest
Apr 10, 2017
From: CHEMBURKAR, SANJAY R.; KNABLE, CARL M.; PETZEL, JAMES; PRUYNE, JULIE J.
To: ABBVIE INC.
Reel/Frame 041937/0828 →
Assignment of Assignor's Interest
Apr 10, 2017
From: RAFAI FAR, ADEL; KRISHNA, GOPAL; DING, MIN
To: THE MEDICINES COMPANY
Reel/Frame 041937/0775 →
Security Interest
Jun 28, 2017
From: MELINTA THERAPEUTICS, INC.
To: SUCHARD SA LLC
Reel/Frame 042854/0753 →
Assignment of Assignor's Interest
Jul 31, 2017
From: MOECK, GREGORY; ARHIN, FRANCIS
To: THE MEDICINES COMPANY
Reel/Frame 043147/0703 →
Assignment of Assignor's Interest
Dec 21, 2017
From: TARGANTA THERAPEUTICS CORP.
To: THE MEDICINES COMPANY
Reel/Frame 044465/0750 →
Release of Security Interest
Jan 5, 2018
From: SUCHARD SA LLC
To: MELINTA SUBSIDIARY CORP. (F/K/A MELINTA THERAPEUTICS, INC.)
Reel/Frame 044547/0939 →
Security Interest
Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Assignment of Assignor's Interest
Mar 1, 2018
From: LI, DANPING; HOPKINS, SCOTT J.; LONGCOR, JARROD
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 045080/0402 →
Assignment of Assignor's Interest
Mar 23, 2018
From: MELINTA THERAPEUTICS, INC.
To: MELINTA SUBSIDIARY CORP.
Reel/Frame 045324/0218 →
Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 045324 Frame: 0218. Assignor(S) Hereby Confirms the Assignment.
Mar 27, 2018
From: MELINTA THERAPEUTICS, INC.
To: MELINTA SUBSIDIARY CORP.
Reel/Frame 045741/0316 →
Security Interest
Jul 25, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; MELINTA SUBSIDIARY CORP.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 046454/0392 →
Merger and Change of Name
Aug 30, 2018
From: MELINTA THERAPEUTICS, INC.; MELINTA SUBSIDIARY CORP.
To: MELINTA SUBSIDIARY CORP.
Reel/Frame 046752/0975 →
Assignment of Assignor's Interest
Oct 17, 2018
From: THE MEDICINES COMPANY
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 047259/0184 →
Assignment of Assignor's Interest
Feb 21, 2019
From: LEHOUX, DARIO; PARR, THOMAS REEVES, JR
To: TARGANTA THERAPEUTICS CORP.
Reel/Frame 048400/0331 →
Assignment of Assignor's Interest
Feb 21, 2019
From: THE MEDICINES COMPANY
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 048407/0911 →